Hotel Indigo Irving — Las Colinas is now open in Irving, Texas. The property is owned and managed by Dallas-based Shreem Capital, led by cofounders Bhavin Patel, CEO and managing partner; Jiger Patel, managing partner; and Dayakar Puskoor, advisor.
“We are bringing a much-needed boutique stay to the heart of Las Colinas," said Bhavin Patel. "The hotel’s design reflects the area’s rich corporate and cultural heritage. Every detail—from the design and décor to the flavors in our restaurant—offers a unique, local touch.”
The new property, located in Irving’s Las Colinas neighborhood, is a 10-minute drive from Dallas Love Field Airport, IHG said. Las Colinas, a master-planned community in Irving, inspired the hotel’s design. It offers an outdoor swimming pool, a fitness center, and 5,400 square feet of meeting and event space.
Carol Hoeller, IHG’s vice president of global brand marketing for Hotel Indigo and voco hotels, said they are excited to open in a neighborhood that embraces culture and curiosity.
“Hotel Indigo Irving – Las Colinas beautifully blends the novel with the familiar, offering a unique escape that’s truly worlds away from the ordinary,” he said. “Opening a Hotel Indigo here was a no-brainer, and we look forward to welcoming travelers to experience the unexpected, both inside and outside the hotel."
Brothers Bhavin and Jiger Patel, along with Puskoor, founded Shreem Capital in 2017 to generate passive income and capital appreciation through hospitality real estate investing. The company manages a portfolio of nine hotels and $100 million in assets, according to its website.
Hotel Indigo is one of six brands in IHG’s luxury and lifestyle portfolio, which the company has recently expanded in the U.S., the statement said. The Irving hotel is IHG’s 13th new property in Texas this year. The Hotel Indigo brand now has 162 open hotels and 128 in the pipeline globally.
In August, IHG marked the 15th anniversary of the IHG Army Hotels program, part of the U.S. Army’s Privatization of Army Lodging initiative. The company reported a 3 percent increase in global RevPAR in the first half of 2024, with 3.2 percent growth in the second quarter, driven by a recovery in U.S. markets.
